Comparing Fluoroscopy and Technological Methods for Guidance During Endovascular Procedures

Comparing Fluoroscopy and Technological Methods for Guidance During Endovascular Procedures Traditional Fluoroscopy Navigation Based on Preoperative CT and Intraoperative DynaCT

The investigators want to test a navigation system for guidance during insertion of stent graft in abdominal aortic aneurysms. The navigation system consists of software developed by SINTEF Health, a custom made catheter with a micro position sensor in the tip and an emitter than induces an electromagnetic field around the patient. Preoperative CT- and intraoperative DynaCT- data are reconstructed into 3 dimensional images. The 3 dimensional images are loaded into the navigation system. Then the magnetic field, in which the patient finds himself, is calibrated with the 3 dimensional images. When the catheter is inserted into the iliac artery and aorta, the position sensor (in the tip of the catheter) is displayed in real time at the exact anatomic location in the 3 dimensional image.

Null hypothesis (H0):

  • Insertion of stent graft is performed equally satisfactorily with fluoroscopy alone as with both fluoroscopy and new navigation technology

Alternative hypothesis (H2):

  • Insertion of stent graft is NOT performed equally satisfactorily with fluoroscopy alone as with both fluoroscopy and new navigation technology

Study Overview

Study Type

Interventional

Enrollment (Actual)

17

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Trondheim, Norway, 7006
        • St Olavs Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • AAA with diameter > 5,0 cm suitable for endovascular technique
  • Normal creatinine
  • > 60 years of age

Exclusion Criteria:

  • Known heart failure or unstable coronary disease
  • Other morbidity than normally contraindicates endovascular treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1

Usage of technological methods and devices to improve intravascular navigation during endovascular aortic repair.

In this arm we first use an optical pointer to allocate the femoral artery ramification (point of incision) and the lower renal artery (upper confinement of stent graft). Later we use an electromagnetically tracked catheter to find and enter the opening in the main stent graft before placing the second limb. For both optical and electromagnetic tracking we use a custom made navigation system based on 3 dimensional CT images

Other Names:
  • Custom made devices in addition to Siemens angiography suite
Active Comparator: 2
Usage of conventional fluoroscopy and angiography for intravascular navigation. In this arm standard endovascular aortic repair is performed. The only means of navigation are fluoroscopy and angiography with overlay function (standard).
Other Names:
  • Siemens angiography suite

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Measure time (s) for defining renal branch
Time Frame: No time frame
No time frame
Measure time (s) for inserting guidewire into "second limb"
Time Frame: 900 sec
900 sec
Number of attempts for inserting guidewire into "second limb"
Time Frame: 900 sec
900 sec
Measure total time (min) for entire procedure
Time Frame: No time frame
No time frame
Measure the total of x-ray dose (mGy/m2)
Time Frame: No time frame
No time frame
Measure the total of contrast fluid used (ml)
Time Frame: No time frame
No time frame
Define type I leak between stent graft and aortic wall
Time Frame: No time frame
No time frame
Measure distance (mm) between stent graft and renal arteries
Time Frame: No time frame
No time frame
Measure difference (mm) in actual position and position in 3D image when pointing at the femoral division with an optic pointer
Time Frame: No time frame
No time frame
Measure difference (mm) of the position of the renal arteries defined by optical pointer and angiography (both marked extracorporal with a needle)
Time Frame: No time frame
No time frame

Secondary Outcome Measures

Outcome Measure
Time Frame
1 questionnaire: "Can 3D image and navigation technology simplify and secure endovascular procedures?"
Time Frame: No time frame
No time frame
2 questionnaire: "Do you believe in further development of this technology?"
Time Frame: No time frame
No time frame
3 questionnaire: "Have both renal arteries unaltered flow?"
Time Frame: No time frame
No time frame

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Frode Manstad-Hulaas, MD, Norwegian University of Science and Technology
  • Study Director: Petter Aadahl, Professor, Norwegian University of Science and Technology
  • Study Director: Toril N Hernes, Professor, SINTEF Health Research

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2007

Primary Completion (Actual)

January 1, 2010

Study Completion (Actual)

April 1, 2010

Study Registration Dates

First Submitted

July 24, 2006

First Submitted That Met QC Criteria

July 24, 2006

First Posted (Estimate)

July 25, 2006

Study Record Updates

Last Update Posted (Estimate)

April 29, 2013

Last Update Submitted That Met QC Criteria

April 26, 2013

Last Verified

April 1, 2013

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aortic Aneurysm, Abdominal

Clinical Trials on Technological Methods

3
Subscribe